摘要
不同细菌与各种肿瘤之间的关系正成为目前科研关注的热点。正常组织中存在某些特定细菌可能促使恶性肿瘤的形成,而某些肿瘤组织的继发性细菌感染又与肿瘤消退相关。尽管仅有少量细菌可促进肿瘤的发生发展,但大多数情况下,细菌对实体肿瘤是有抑制作用的,并可运用于肿瘤靶向细菌疗法,以发挥抗癌作用。
Associations between different bacteria and various tumours have becoming the focus of current research. The presence of bacteria within healthy tissues may be tumourigenesis, while there may be a correlation between spontaneous bacterial infection and tumour regression. Though a few bacteria are playing a causative role in tumor, mostly bacteria inhibit solid tumours, and can be utilized in tumour-specific bacterial therapy for cancer treatment.
引文
1 Polk DB,Peek RM Jr.Helicobacter pylori:gastric cancer and beyond[J].Nat Rev Cancer,2010,10(6):403-414.
2 Hoption Cann SA,van Netten JP,van Netten C.Dr William Coley and tumour regression:a place in history or in the future[J].Postgrad Med J,2003,79(938):672-680.
3 Grivennikov SI,Greten FR,Karin M.Immunity,inflammation,and cancer[J].Cell,2010,140(6):883-899.
4 Coussens LM,Werb Z.Inflammation and cancer[J].Nature,2002,420(6917):860-867.
5 Karin M,Greten FR.NF-κB:linking inflammation and immunity to cancer development and progression.Nat Rev Immunol,2005,5(10):749-759.
6 Goodwin AC,Destefano CE,Wu S,et al.Polyamine catabolism contributes to enterotoxigenic.Bacteroides fragilis-induced colon tumorigenesis[J].Proc Natl Acad Sci U S A,2011,108(37):15345-15359.
7 Waris G,Ahsan H.Reactive oxygen species:role in the development of cancer and various chronic conditions[J].J Carcinog,2006,5:14.
8 Buti L,Spooner E,Van der Veen AG,et al.Helicobacterpylori cytotoxin-associated gene A(Cag A)subverts the apoptosis-stimulating protein of p53(ASPP2)tumor suppressor pathway of the host[J].Proc Natl Acad Sci U S A,2011,108(22):9238-9243.
9 Preuss I,Hildebrand D,Orth JH,et al.Pasteurella multocida toxin is a potent activator of anti-apoptotic signalling pathways[J].Cell Microbiol,2010,12(8):1174-1185.
10 Jinadasa RN,Bloom SE,Weiss RS,et al.Cytolethal distending toxin:a conserved bacterial genotoxin that blocks cell cycle progression,leading to apoptosis of a broad range of mammalian cell lineages[J].Microbiology,2011,157(Pt 7):1851-1875.
11 Abdulamir AS,Hafidh RR,Abu Bakar F.The association of Streptococcus bovis/gallolyticus with colorectal tumors:the nature and the underlying mechanisms of its etiological role[J].J Exp Clin Cancer Res,2011,30:11.
12 Sears CL.Enterotoxigenic Bacteroides fragilis:a rogue among symbiotes[J].Clin Microbiol Rev,2009,22(2):349-369.
13 Rhee KJ,Wu S,Wu X,et al.Induction of persistent colitis by a human commensal,enterotoxigenic Bacteroides fragilis,in wild-type C57BL/6 mice[J].Infect Immun,2009,77(4):1708-1718.
14 Buc E,Dubois D,Sauvanet P,et al.High prevalence of mucosaassociated E.Coli producing cyclomodulin and genotoxin in colon cancer[J].PLo S One,2013,8(2):e56964.
15 Cuevas Rammos G,Petit CR,Marcq I,et al.Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells[J].Proc Natl Acad Sci U S A,2010,107(25):11537-11542.
16 Cougnoux A1,Dalmasso G,Martinez R,et al.Bacterial genotoxin colibactin promotes colon tumour growth by inducing a senescenceassociated secretory phenotype[J].Gut,2014,Epub ahead of print
17 Uronis JM,Muhlbauer M,Herfarth HH,et al.Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility[J].PLo S One,2009,4(6):e6026.
18 Kitajima S,Morimoto M,Sagara E,et al.Dextran sodium sulfateinduced colitis in germ-free IQI/Jic mice[J].Exp Anim,2001,50(5):387-395.
19 Shen XJ,Rawls JF,Randall T,et al.Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas[J].Gut Microbes,2010,1(3):138-147.
20 Yoshimoto S,Loo TM,Atarashi K,et al.Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome[J].Nature,2013,499(7456):97-101.
21 Kurkivuori J,Salaspuro V,Kaihovaara P,et al.Acetaldehyde production from ethanol by oral streptococci[J].Oral Oncol,2007,43(2):181-186.
22 Mager DL,Haffajee AD,Devlin PM,et al.The salivary microbiota as a diagnostic indicator of oral cancer:a descriptive,non-randomized study of cancer-free and oral squamous cell carcinoma subjects[J].J Translational Med,2005,3:27.
23 Farrell JJ,Zhang L,Zhou H,et al.Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer[J].Gut,2012,61(4):582-588.
24 Engberts MK,Verbruggen BS,Boon ME,et al.Candida and dysbacteriosis:a cytologic,population-based study of 100,605asymptomatic women concerning cervical carcinogenesis[J].Cancer,2007,111(5):269-274.
25 汪万英,赵芳芳,何杰,等.p53、p16和细菌L型DNA在卵巢肿瘤中的表达及意义[J].中国微生态学杂志,2005,17(5):359-361.
26 Wei MQ,Ellem KA,Dunn P,et al.Facultative or obligate anaerobic bacteria have the potential for multimodality therapy of solid tumours[J].Eur J Cancer,2007,43(3):490-496.
27 Baban CK,Cronin M,O'Hanlon D,et al.Bacteria as vectors for gene therapy of cancer[J].Bioeng Bugs,2010,1(6):385-394.
28 Cronin M,Akin AR,Collins SA,et al.High resolution in vivo bioluminescent imaging for the study of bacterial tumour targeting[J].PLo S One,2012,7(1):e30940.
29 周易明,刘常星,邬剑华,等.减毒鼠伤寒沙门氏菌作为肿瘤基因治疗载体的低毒性和靶向性研究[J].复旦学报(医学版),2008,35(3):336-341.
30 Leschner S,Westphal K,Dietrich N,et al.Tumor invasion of Salmonella enterica serovar typhimurium is accompanied by strong hemorrhage promoted by TNF-alpha[J].PLo S One,2009,4(8):e6692.
31 Leschner S,Deyneko IV,Lienenklaus S,et al.Identification of tumorspecific Salmonella Typhimurium promoters and their regulatory logic[J].Nucleic Acids Res,2012,40(7):2984-2994.
32 Gravekamp C,Paterson Y.Harnessing Listeria monocytogenes to target tumors[J].Cancer Biol Ther,2010,9(4):257-265.
33 Saccheri F,Pozzi C,Avogadri F,et al.Bacteria-induced gap junctions in tumors favor antigen cross-presentation and antitumor immunity[J].Sci Transl Med,2010,2(44):44ra57.
34 Srikanth CV,Wall DM,Maldonado Contreras A,et al.Salmonella pathogenesis and processing of secreted effectors by caspase-3[J].Science,2010,330(6002):390-393.
35 dos Santos SA,de Andrade Júnior DR,de Andrade DR.TNF-αproduction and apoptosis in hepatocytes after Listeria monocytogenes and Salmonella Typhimurium invasion[J].Rev Inst Med Trop Sao Paulo,2011,53(2):107-112.
36 Ganai S,Arenas RB,Sauer JP,et al.In tumors Salmonella migrate away from vasculature toward the transition zone and induce apoptosis[J].Cancer Gene Ther,2011,18(7):457-466.
37 Zhao M,Suetsugu A,Ma H,et al.Efficacy against lung metastasis with a tumor-targeting mutant of Salmonella typhimurium in immunocompetentmice[J].Cell Cycle,2012,11(1):187-193.
38 Nagakura C,Hayashi K,Zhao M,et al.Efficacy of a geneticallymodified Salmonella typhimurium in an orthotopic human pancreatic cancer in nudemice[J].Anticancer Res,2009,29(6):1873-1878.
39 Momiyama M,Zhao M,Kimura H,et al.Inhibition and eradication of human glioma with tumor-targeting Salmonella typhimurium in an orthotopic nude-mouse model[J].Cell Cycle,2012,11(3):628-632.
40 Hayashi K,Zhao M,Yamauchi K,et al.Systemic targeting of primary bone tumor and lung metastasis of high-grade osteosarcoma in nude mice with a tumor-selective strain of Salmonella typhimurium[J].Cell Cycle,2009,8(6):870-875.
41 Shao C,Yang B,Zhao L,et al.Tumor suppressor gene RBM5delivered by attenuated Salmonella inhibits lung adenocarcinoma through diverseapoptotic signaling pathways[J].World J Surg Oncol,2013,11:123.
42 Jellbauer S,Panthel K,Hetrodt JH,et al.CD8 T-cell induction against vascular endothelial growth factor receptor 2 by Salmonella for vaccination purposesagainst a murine melanoma[J].PLo S One,2012,7 (4):e34214.
43 Sorenson BS,Banton KL,Augustin LB,et al.Antioxidant oils and Salmonella enterica Typhimurium reduce tumor in an experimental model of hepaticmetastasis[J].Onco Targets Ther,2011,4:59-69.
44 Jiang Z,Zhao P,Zhou Z,et al.Using attenuated Salmonella typhi as tumor targeting vector for MDR1 si RNA delivery[J].Cance Gene Ther,2007,6(4):555-560.
45 Jeong J H,Kim K,Lim effect of the mitochondrial target domain of Noxa delivered by an engineered Salmonella typhimurium[J].PLo S One,2014,9(1):e80050.
46 Fraillery D,Baud D,Pang SY,et al.Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccineagainst cervical cancer and typhoid fever[J].Clin Vaccine Immunol,2007,14(10):1285-1295.
47 Jia Y,Yin Y,Duan F,et al.Prophylactic and therapeutic efficacy of an attenuated Listeria monocytogenes-based vaccine delivering HPV16E7 in a mouse model Int[J].J Mol Med,2012,30(6):1335-1342.
48 Maciag PC,Radulovic S,Rothman J.The first clinical use of a liveattenuated Listeria monocytogenes vaccine:a Phase I safety study of Lm-LLO-E7 in patients with advanced carcinoma of the cervix[J].Vaccine,2009,27(30):3975-83.
49 Pijkeren J P,Morrissey D,Monk I R,eta l.Anovel Listeia monocytogenes-based DNA delivery system for cancer gene therapy[J].Hum Gene Ther,2010,21(4):405-416.